CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS
Authors
Alberto Zaniboni
Angela Damato
+22 more
Antonio Cassata
Armando Orlandi
Bruno Daniele
Carlo Barone
Carmine Pinto
Domenico Bilancia
Domenico Corsi
Emiliano Tamburini
Evaristo Maiello
Francesca Fenizia
Francesco Di Costanzo
Francesco Ferrau
Giovanni Luca Frassinetti
Giuseppe Tonini
Héctor Soto Parra
Lazzaro Repetto
Maria Alessandra Calegari
Maria Giulia Zampino
Nicola Normanno
Rosario Vincenzo Iaffaioli
Salvatore Pisconti
Stefania Gori
Publication date
Publisher
'Future Medicine Ltd'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.2217%2Ffon-2017-05...
Last time updated on 28/10/2020